AMBioVessel – 3D-printed, tailor-made bioreactors for pharma and medicine

The consortium will develop within the framework of a Eurostars collaboration project the AMBioVessel system, the first application driven designed bioreactor produced by additive manufacturing.

Key data

Description

The consortium will develop within the framework of a Eurostars collaboration project the AMBioVessel system, the first application driven designed bioreactor produced by additive manufacturing. It will introduce a paradigm shift from tuning environmental parameters to modifying the spatial environment of the culture. The AMBioVessel offers perfect cultivation environments to achieve product yields beyond the current bioreactor geometry limitations that allow faster time-to-market and cost reduction for bio-manufacturing and cell therapy, our main target markets.